-
公开(公告)号:AU2015269219A1
公开(公告)日:2016-12-08
申请号:AU2015269219
申请日:2015-06-05
Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER , THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: ADUSUMILLI PRASAD S , SADELAIN MICHEL , DIMITROV DIMITER S , FENG YANG
IPC: A61K39/00
Abstract: The presently disclosed subject matter provides for methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to chimeric antigen receptors (CARs) that specifically target human mesothelin, and immunoresponsive cells comprising such CARs. The presently disclosed mesothelin-targeted CARs have enhanced immune-activating properties, including anti-tumor activity.
-
公开(公告)号:AU2011279008B2
公开(公告)日:2016-06-23
申请号:AU2011279008
申请日:2011-07-15
Applicant: ICAHN SCHOOL MED MOUNT SINAI , UNIV ROCKEFELLER , THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: COLLER BARRY S , THOMAS CRAIG J , FILIZOLA MARTA , MCCOY JOSHUA , HUANG WENWEI , SHEN MIN
IPC: C07D513/04 , A61K31/497
Abstract: The present invention relates to compounds and compositions useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.
-
公开(公告)号:AU2014273917A1
公开(公告)日:2015-12-17
申请号:AU2014273917
申请日:2014-06-02
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: JOHNSON JEFFREY A , HENEINE WALID M , LIPSCOMB JONATHAN T , WEI XIERONG
IPC: C12Q1/70
Abstract: Disclosed are compositions including primers and probes, which are capable of interacting with the disclosed nucleic acids, such as the nucleic acids encoding the reverse transcriptase, protease, or integrase of HIV as disclosed herein. Thus, provided is an oligonucleotide comprising any one of the nucleotide sequences set for in SEQ ID NOS: 1-89, 96-122, and 124-151. Also provided are the oligonucleotides consisting of the nucleotides as set forth in SEQ ID NOS: 1-89, 96-122, and 124-151. Each of the disclosed oligonucleotides is a probe or a primer. Also provided are mixtures of primers and probes and for use in RT-PCR and primary PCR reactions disclosed herein. Provided are methods for the specific detection of several mutations in HIV simultaneously or sequentially. Mutations in the reverse transcriptase, protease, or integrase of HIV can be detected using the methods described herein.
-
公开(公告)号:AU2007354861B2
公开(公告)日:2013-03-21
申请号:AU2007354861
申请日:2007-06-15
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES , THE UNIV OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH
Inventor: CAO JIANJING , CYRIAC GEORGE C , GRUNDT PETER , NEWMAN AMY HAUCK , LUEDTKE ROBERT
IPC: C07D295/145 , A61P25/00 , C07D401/12
Abstract: Dopamine D
-
公开(公告)号:AU2002364121C1
公开(公告)日:2010-02-18
申请号:AU2002364121
申请日:2002-11-21
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: NEWMAN JASON T , MURPHY BRIAN R , SKIADOPOULOS MARIO H , COLLINS PETER L
IPC: C12P21/04 , A61K20060101 , A61K35/76 , A61K39/00 , A61K39/155 , A61P31/14 , C07K14/115 , C12N7/00 , C12N7/01 , C12N7/04 , C12N15/45 , C12N15/86
-
公开(公告)号:RS65760B1
公开(公告)日:2024-08-30
申请号:RSP20240825
申请日:2014-03-13
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: BOYINGTON JEFFREY , GEORGIEV IVELIN STEFANOV , PANCERA MARIE , SOTO CINQUE , SRIVATSAN SANJAY , STEWART-JONES GUILLAUME , KWONG PETER D , GRAHAM BARNEY S , MCLELLAN JASON S , JOYCE MICHAEL GORDON , KANEKIYO MASARU , ZHANG BAOSHAN , CHEN LEI , CHEN MAN , CHUANG GWO-YU , GORMAN JASON , YANG YONGPING , ZHOU TONGQING , SASTRY MALLIKA , OFEK GILAD
IPC: C07K14/135 , A61K38/10 , A61K39/00 , A61K39/155 , A61P43/00 , C12N15/45 , C12N15/62
-
97.
公开(公告)号:AU2016302237B2
公开(公告)日:2022-08-04
申请号:AU2016302237
申请日:2016-08-03
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: SCHLOM JEFFREY , PALENA CLAUDIA M
IPC: A61K39/00
Abstract: The invention provides Brachyury deletion mutant polypeptides, nucleic acids encoding the polypeptides, non-yeast vectors comprising the nucleic acids, non-yeast cells, and methods of use.
-
公开(公告)号:AU2017359330B2
公开(公告)日:2022-03-10
申请号:AU2017359330
申请日:2017-11-08
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: BHARTI KAPIL , SONG MIN JAE , QUINN RUSSELL LOUIS
Abstract: Methods are disclosed for fabricating a three-dimensional engineered blood retinal barrier (BRB) comprising a choroid and retinal pigment epithelial cells. The methods include the use of bioprinting. Also disclosed is a three-dimensional engineered BRB, and its use. Methods are also disclosed for using the three-dimensional engineered BRB, such as for the treatment of retinal degeneration in a subject or screening. A three-dimensional printing insert that is adapted for bioprinting on a culture substrate sheet that is securely retained within and exposed through a printing frame is also disclosed.
-
公开(公告)号:AU2017346885B2
公开(公告)日:2021-10-21
申请号:AU2017346885
申请日:2017-10-18
Applicant: INTIMA BIOSCIENCE INC , UNIV MINNESOTA , THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: MORIARITY BRANDEN , WEBBER BEAU , CHOUDHRY MODASSIR , ROSENBERG STEVEN A , PALMER DOUGLAS C , RESTIFO NICHOLAS P
IPC: C12N15/11 , A61K35/17 , C12N5/0783 , C12N9/10
Abstract: Genetically modified compositions, such as non-viral vectors and tumor infiltrating lymphocytes, for the treatment of gastrointestinal cancer are disclosed. Disclosed are methods of utilizing a CRISPR system to generate genetically modified compositions. Also disclosed are the methods of making and using the genetically modified compositions for the treatment of gastrointestinal cancer.
-
公开(公告)号:AU2015369712B2
公开(公告)日:2020-05-07
申请号:AU2015369712
申请日:2015-12-22
Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES , UNIV NORTH CAROLINA CHAPEL HILL
Inventor: BOXER MATTHEW BRIAN , ROHDE JASON MATTHEW , PRAGANI RAJAN , LIU LI , DAVIS MINDY IRENE EMILY , BRIMACOMBE KYLE RYAN , SHEN MIN , SIMEONOV ANTON , KARAVADHI SURENDRA , URBAN DANIEL JASON , JADHAV AJIT , WANG XIAODONG , MCIVER ANDREW LOUIS
IPC: C07D215/22 , A61K31/4436 , A61K31/4545 , A61K31/4704 , A61K31/4725 , A61K31/5377 , A61K31/55 , A61P35/00 , C07D401/04 , C07D417/04 , C07D417/14 , C07D471/04
Abstract: Compounds of Formula I and Formula II and the pharmaceutically acceptable salts thereof are disclosed The variables A, B, Y, Z, X
-
-
-
-
-
-
-
-
-